New imaging technology reveals previously unseen immune cell patterns in tissue
BCR-MERFISH is an imaging technology that maps antibody-producing plasma cells in tissue. It adapts MERFISH, a method that uses microscopy to measure RNA and show which genes are active. This matters because researchers can study cell identity and exact location together. Earlier imaging could identify cell types and states, but plasma cells that looked nearly identical could produce antibodies aimed at very different targets. BCR-MERFISH distinguishes groups using selected features of their antibody receptor genes. It also measures gene activity in surrounding cells, adding context to the map. Researchers demonstrated the method in mouse small intestines, imaging more than 300,000 cells and identifying 434 plasma-cell groups. The technology is not a diagnostic test or treatment. The team is studying human biopsy samples, and further research is needed to translate findings into patient care. The approach could help investigate inflammatory bowel disease, tumors, lymphomas, infections and other conditions.
What is BCR-MERFISH, and what can it reveal about immune cells that earlier imaging methods could not?
BCR-MERFISH is an imaging technology that maps antibody-producing plasma cells in tissue. It adapts MERFISH, a method that uses microscopy to measure RNA and show which genes are active. This matters because researchers can study cell identity and exact location together.
Earlier imaging could identify cell types and states, but plasma cells that looked nearly identical could produce antibodies aimed at very different targets. BCR-MERFISH distinguishes groups using selected features of their antibody receptor genes. It also measures gene activity in surrounding cells, adding context to the map.
Researchers demonstrated the method in mouse small intestines, imaging more than 300,000 cells and identifying 434 plasma-cell groups. The technology is not a diagnostic test or treatment. The team is studying human biopsy samples, and further research is needed to translate findings into patient care. The approach could help investigate inflammatory bowel disease, tumors, lymphomas, infections and other conditions.
How many cells and distinct plasma-cell groups did researchers identify in the mouse intestine?
The researchers imaged more than 300,000 cells in two extended sections of mouse intestinal tissue. Within those maps, they identified 434 distinct groups of plasma cells. Plasma cells produce antibodies, and the groups were distinguished by their antibody receptor gene usage.
The scale mattered because earlier imaging could identify cell types and states but could not readily separate plasma cells with different antibody targets. BCR-MERFISH combines information about selected receptor gene features with a cell’s location. It also measures gene activity in surrounding cells, giving researchers a more detailed view of the tissue.
These figures come from a demonstration in mouse small intestine, not from a clinical test or human study. The researchers are also studying human biopsy samples through clinical collaborations, including samples from people with inflammatory bowel disease. Further research will be needed to connect the maps to patient care.
What unexpected spatial pattern did the researchers find among antibody-producing cells in the intestine?
The researchers found that some groups of antibody-producing plasma cells formed clusters along the mouse intestine. The cells were not spread evenly throughout the tissue. Senior author Jeffrey R. Moffitt said the team had not expected to see these clusters.
BCR-MERFISH made the pattern visible by mapping plasma-cell groups according to selected antibody receptor gene features while also showing where cells sat in the tissue. This is useful because plasma cells can look alike under a microscope even when they produce antibodies that recognize different targets. In two extended intestinal sections, the researchers mapped more than 300,000 cells and identified 434 groups.
The meaning of the clusters remains unknown. The researchers do not yet know what causes them or how they affect immune function. The maps offer a way to investigate those questions and to compare immune-cell patterns in healthy and diseased tissue.
How did the number and variety of plasma-cell groups differ between mice with gut microbes and germ-free mice?
Mice raised with typical gut microbes had more plasma cells and greater diversity among the identifiable plasma-cell groups than germ-free mice. Germ-free mice, which were raised without microorganisms, had fewer plasma cells and less diversity. The article does not give exact counts for either comparison.
Researchers used BCR-MERFISH to map plasma-cell groups in intestinal tissue based on selected antibody receptor gene features. That let them compare not only where cells were located but also which groups could be identified. The result was in line with what the researchers expected: germ-free mice had fewer plasma cells and less variety among the groups.
This comparison shows how the technology can be used to examine immune-cell patterns in different conditions. It does not establish why the groups differed or what the differences mean for immune function. The team’s maps and further study could help investigate how immune cells behave in the intestine and in disease.
How could locating different plasma-cell groups help researchers study diseases such as Crohn’s disease and ulcerative colitis?
In Crohn’s disease and ulcerative colitis, tissue architecture changes and plasma cells gather at affected sites. Locating different plasma-cell groups could help researchers examine which groups are present there and how they relate to the inflamed tissue. This matters because the cells produce antibodies, but different plasma cells can recognize different targets.
BCR-MERFISH maps selected antibody receptor gene features alongside cell location and gene activity in surrounding cells. Earlier imaging had limited ability to distinguish groups of antibody-producing cells within these tissues and study their relationships to nearby cells. The new method could make those comparisons possible at finer spatial resolution.
The technology is a research tool, not a diagnostic test or treatment. Moffitt’s laboratory is studying human biopsy samples through clinical collaborations, including samples from patients with inflammatory bowel disease. Further research is needed before findings can inform patient care. The method may also support investigation of tumors, B-cell lymphomas and other conditions involving adaptive immunity.
What do plasma cells do, and how do the antibodies they produce help the body?
Plasma cells are immune cells that produce antibodies. The article describes antibodies as proteins that help the body recognize and fight threats. This makes plasma cells important to the immune response, while also making it useful to know which antibody-producing cells are present in a particular tissue.
The targets can differ even when two plasma cells look nearly identical under a microscope. BCR-MERFISH distinguishes groups using selected antibody receptor gene features and maps where they are located. It can also measure gene activity in surrounding cells, helping researchers view plasma cells in the context of their tissue.
In mouse small intestine, the researchers identified 434 distinct plasma-cell groups across two extended sections of tissue. They also found unexpected clusters of some groups. The causes and immune meaning of the clusters remain unknown. By linking cell identity to location, the method could help researchers study immune activity in inflammation, infection, tumors and other disease settings.
What is the adaptive immune system, and how does it recognize different threats?
The article focuses on the adaptive immune system’s antibody-producing plasma cells, but it does not give a full definition of the system. In standard biology, adaptive immunity is the part of the immune system that responds to particular targets and can develop targeted responses. This differs from the body’s more general defenses.
The article explains that plasma cells make antibodies, proteins that help the body recognize and fight threats. Antibodies can recognize different targets, and two plasma cells that look nearly identical may produce antibodies aimed at very different ones. BCR-MERFISH uses selected antibody receptor gene features to distinguish plasma-cell groups and locate them in tissue.
The technology lets researchers study this adaptive immune activity in its spatial context, including gene activity in surrounding cells. In mouse intestine, it revealed 434 distinct groups and unexpected clusters. Researchers do not yet know what causes those clusters or what they mean for immune function. The method could help investigate disease, but further research is needed for patient-care advances.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web